Optimization Of Glycaemic Control And Prevention Of Hypoglycaemia And Microvascular Complications In Children And Adolescents With Type 1 Diabetes
Funder
National Health and Medical Research Council
Funding Amount
$452,051.00
Summary
Type 1 diabetes is a complex life-long disease that has onset in the young and carries a significant burden. Good management is crucial as it helps prevent the serious long term complications of the disease such as blindness and kidney disease. Low blood glucose or hypoglycaemia is a common side effect of insulin treatment. This research aims to explore ways to treat the disease more effectively, prevent hypoglycaemia and other diabetes complications and in so doing improve the outcomes for youn ....Type 1 diabetes is a complex life-long disease that has onset in the young and carries a significant burden. Good management is crucial as it helps prevent the serious long term complications of the disease such as blindness and kidney disease. Low blood glucose or hypoglycaemia is a common side effect of insulin treatment. This research aims to explore ways to treat the disease more effectively, prevent hypoglycaemia and other diabetes complications and in so doing improve the outcomes for young people with diabetes.Read moreRead less
Improving Outcomes Of Diabetes And Related Conditions For Indigenous Australians: Causes, Intervention, System Change
Funder
National Health and Medical Research Council
Funding Amount
$274,218.00
Summary
My research program is focused on improving outcomes of diabetes and related conditions for Indigenous Australians through: (i) describing causal pathways; (ii) addressing health system change; and (iii) conducting clinical intervention studies.
Clinical Trials And Registries To Prevent Blindness For Macular Disease
Funder
National Health and Medical Research Council
Funding Amount
$467,961.00
Summary
Injection of drugs into the eye is an unprecedented breakthrough in the treatment of macular diseases, however many questions must be addressed for our patients with diabetic retinopathy and macular degeneration to reap the full benefits. My clinical research unit will conduct our own clinical trials, such as testing a new laser that has never been used in the retina. My observational studies unit will track “real world” outcomes of treatment of retinal disease in a large group of Australians.